VR and Chronic Pain Pilot Usability Study
Virtual Reality and Chronic Pain Pilot Usability Study
1 other identifier
interventional
16
1 country
1
Brief Summary
This is a pilot feasibility and usability study of a virtual reality device for patients with chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2021
CompletedFirst Posted
Study publicly available on registry
June 11, 2021
CompletedStudy Start
First participant enrolled
August 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 7, 2022
CompletedSeptember 29, 2023
September 1, 2023
1.2 years
June 8, 2021
September 27, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
% of participants contacted that are enrolled
We will determine feasibility by measuring the % of participants that are contacted who are enrolled.
at study 1 day visit
Secondary Outcomes (3)
Satisfaction with VR experience
at study 1 day visit
Change in Mood
at study 1 day visit
Change in Pain intensity
at study 1 day visit
Study Arms (1)
EaseVRx sessions
EXPERIMENTALThis is a study of patients with chronic pain to identify interest in participating in a large VR trial and, for those willing to join us to test the device in person, to pilot 2 sessions of VR to assess usability and collect preliminary data on pain and mood and to obtain data on patient satisfaction with device use. The entire session will last 45 minutes to 1 hour. All patients recruited will be in the active arm; this is not a randomized pilot study.
Interventions
Participants will experience 2 sessions of the EaseVRx device for chronic pain
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Chronic pain (using self-report) with pain intensity \>=4 and confirmed by ICD-10 codes in medical record
- Fluency in English
You may not qualify if:
- Inability to give informed consent
- Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines
- Medical condition predisposing to nausea or dizziness
- Hypersensitivity to flashing light or motion
- No stereoscopic vision or severe hearing impairment
- Injury to eyes, face, or neck that prevents use of VR headset
- Currently pregnant, by self-report
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montefiore Medical Center
The Bronx, New York, 10467, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hector R Perez, MD, MS
Albert Einstein College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2021
First Posted
June 11, 2021
Study Start
August 3, 2021
Primary Completion
October 7, 2022
Study Completion
October 7, 2022
Last Updated
September 29, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share